Evidence map›Paper›PMID 38243642›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Peptide Nucleic Acid Clamp-Assisted Photothermal Multiplexed Digital PCR for Identifying SARS-CoV-2 Variants of Concern.

Lexiang Zhang, Rokshana Parvin, Siyue Lin, Mingshuo Chen, Ruixuan Zheng, Qihui Fan, Fangfu Ye

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lexiang ZhangJoint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.ORCID 0000-0003-0374-4382
Rokshana ParvinOujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health); Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.
Siyue LinDepartment of Biomedical Engineering, Columbia University, New York, NY, 10027, USA.
Mingshuo ChenOujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health); Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.
Ruixuan ZhengJoint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Qihui FanBeijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China, 100190.
Fangfu YeJoint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.

Funding

Key Laboratory of Structural Malformations in Children of Zhejiang Province ZJET2301ZKey Projects of Wenzhou Science and Technology Bureau ZG2023013National Natural Science Foundation of China 12325405National Natural Science Foundation of China 22307098National Natural Science Foundation of China 31972763the National Key Research and Development Program of China 2022YFA1405002the Youth Innovation Promotion Association of CAS 2021007Wenzhou Basic Research Projects Y2023147Wenzhou high-level innovation team Development-and-application-team-of-functional-liver-cancer-on-a-chipWenzhou Institute, University of Chinese Academy of Sciences WIUCASQD2021012Zhejiang Provincial Natural Science Foundation of China LGF22C100003
6 · The paper itself

Abstract

The unprecedented demand for variants diagnosis in response to the COVID-19 epidemic has brought the spotlight onto rapid and accurate detection assays for single nucleotide polymorphisms (SNPs) at multiple locations. However, it is still challenging to ensure simplicity, affordability, and compatibility with multiplexing. Here, a novel technique is presented that combines peptide nucleic acid (PNA) clamps and near-infrared (NIR)-driven digital polymerase chain reaction (dPCR) to identify the Omicron and Delta variants. This is achieved by simultaneously identifying highly conserved mutated signatures at codons 19, 614, and 655 of the spike protein gene. By microfluidically introducing graphene-oxide-nanocomposite into the assembled gelatin microcarriers, they achieved a rapid temperature ramping-up rate and switchable gel-to-sol phase transformation synchronized with PCR activation under NIR irradiation. Two sets of duplex PCR reactions, each classifying respective PNA probes, are emulsified in parallel and illuminated together using a homemade vacuum-based droplet generation device and a programmable NIR control module. This allowed for selective amplification of mutant sequences due to single-base-pair mismatch with PNA blockers. Sequence-recognized bioreactions and fluorescent-color scoring enabled quick identification of variants. This technique achieved a detection limit of 5,100 copies and a 5-fold quantitative resolution, which is promising to unfold minor differences and dynamic changes.

Indexed as

COVID-19Peptide Nucleic AcidsColoring AgentsCOVID-19 TestingHumansSARS-CoV-2Coloring AgentsPeptide Nucleic Acidsdigital PCRdroplet microfluidicspeptide nucleic acidSARS‐CoV‐2 variantsingle nucleotide polymorphisms

Identifiers

PMID38243642
PMCPMC10987151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.